Edit
Avisa
http://www.avisapharma.com/Last activity: 04.05.2021
Active - Reference to Avisa Diagnostics Inc.
A venture-backed healthcare company commercializing a rapid, point-of-care breath test for the diagnosis of pulmonary infections
Employees: 11-50
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Cowtown An... | cowtownang... |
| - | Darco Capi... | darcocapit... |
Mentions in press and media 7
| Date | Title | Description |
| 04.05.2021 | Avisa Diagnostics Inc. (Formerly, FogChain Corp.) Announces Closing of Reverse Takeover Transaction | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the “Company”) is pleased to announce th... |
| 21.04.2016 | Avisa Pharma developing 10-minute tuberculosis breath test | This pilot study is meant to set the ground for global clinical trials, which are planned for 2017. Currently, the quickest diagnostic for tuberculosis takes about three hours – which brings value to the 10-minutes-or-less approach, Avisa s... |
| 31.10.2014 | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | $33 million in equity raised, closing out a $48 million Series E round The funding will bring Aileron candidate ALRN-6924 – a drug that works to activate a solid tumor suppressor protein called p53 – to clinical trial. The company says its ... |
| 29.10.2014 | A breathalyzer that detects diseases like TB, hospital-acquired pneumonia gets funded | “Inhaled 13C-labeled urea, AV-U13, is delivered to the entire lung and rapidly converted by bacterial urease into 13CO2,” the company says. This 13CO2 is then exhaled and detected by the company’s spectrophotometer. “The entire breath test ... |
| - | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC. Here are the new funding notices fro... |
| - | Avisa Pharma developing 10-minute tuberculosis breath test | Avisa Pharma, which is developing a breath test to detect respiratory diseases like pneumonia, COPD and tuberculosis, is raising a small debt round. The New Mexico upstart has raised $914,359 of a potential $2 million, according to a regula... |
| - | A breathalyzer that detects diseases like TB, hospital-acquired pneumonia gets funded | Seems these days as though breath analysis startups are all the rage – creating diagnostics that provide quick-turnover disease diagnosis. They’re primarily targeted to the public health set – allowing frontline health workers diagnose dise... |